CapNostics

Newtown Square, United States Founded: 2013 • Age: 13 yrs Acquired By Lucid Diagnostics
FDA-cleared swallowable device is used for non-endoscopic GI screening.
Annual revenue - Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors 1 Known backers
Products - Services tracked
Competitors 10 Brand Intelligence

About CapNostics

CapNostics is a company based in Newtown Square (United States) founded in 2013 was acquired by Lucid Diagnostics in October 2021. CapNostics operates in a competitive market with competitors including Auris Health, Apollo Endo, MedInTech, UnivLabs and Aohua Endoscopy, among others.

  • Headquarter Newtown Square, United States
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
Operational Areas
Healthcare → Medical Devices & Diagnostics Unlock Sub-Sector Unlock Segment
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    Not available
  • Investors
  • Employee Count
    Not available
  • Acquired by
    Lucid Diagnostics

    (Oct 07, 2021)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of CapNostics

Premium access

Detailed funding history for CapNostics

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investors in CapNostics

CapNostics has secured backing from 1 investor. Prominent investors backing the company include Lucid Diagnostics.

All
Investor Description Founded Year Domain Location
Diagnostic kits for esophageal cancer biomarkers are developed.
Locked Locked Locked
Premium access

Investor details for CapNostics

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by CapNostics

Investments
Premium access

Investment portfolio details for CapNostics

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - CapNostics

Premium access

Detailed financials for CapNostics

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Capnostics Comparisons

CapNostics Primary company
Description
FDA-cleared swallowable device is used for non-endoscopic GI...
Location
Newtown Square, United States
Founded Year
2013
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for CapNostics

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of CapNostics

CapNostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Auris Health, Apollo Endo, MedInTech, UnivLabs and Aohua Endoscopy, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Robotic microsurgical systems for endoscopy are developed.
Locked Locked Locked
Therapeutic devices for obesity and GI disorders are developed.
Locked Locked Locked
Medical device technologies are developed with AI for diagnostics.
Locked Locked Locked
Endoscopic medical devices are designed and manufactured for surgical applications.
Locked Locked Locked
Endoscopic devices and accessories are developed for medical use.
Locked Locked Locked
Endoscopic imaging devices and solutions are developed and marketed.
Premium access

Detailed competitors of CapNostics

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Capnostics

Premium access

Complete news archive for CapNostics

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about CapNostics

CapNostics was founded in 2013.

CapNostics is headquartered in Newtown Square, United States. It is registered at Newtown Square, Pennsylvania, United States.

Founded in 2013 and based in Newtown Square, United States, CapNostics operates in the medical device sector. A swallowable device for non-endoscopic specimen collection is provided to funded cancer research institutions, supporting lab tests for early detection of Barretts Esophagus, upper GI cancers, and H. pylori. CE Class I certification is being completed to enable marketing in the European Union.

CapNostics's top competitors include Auris Health, Apollo Endo and Pentax Medical.

CapNostics has 1 investor. Key investors include Lucid Diagnostics.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available